Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
about
Association of betel nut with carcinogenesis: revisit with a clinical perspectiveDynamic role of myofibroblasts in oral lesionsAssociation of Smoking, Alcohol Use, and Betel Quid Chewing with Epigenetic Aberrations in Cancers.Activation of TGF-β pathway by areca nut constituents: a possible cause of oral submucous fibrosisElevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.Molecular profiling of the invasive tumor microenvironment in a 3-dimensional model of colorectal cancer cells and ex vivo fibroblastsαVβ6 integrin promotes corneal wound healing.Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformationBetel nut chewing, oral premalignant lesions, and the oral microbiome.Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.Molecular and cellular cues of diet-associated oral carcinogenesis--with an emphasis on areca-nut-induced oral cancer development.Areca nut alkaloids induce irreparable DNA damage and senescence in fibroblasts and may create a favourable environment for tumour progression.Inhibition of Tanshinone IIA, salvianolic acid A and salvianolic acid B on Areca nut extract-induced oral submucous fibrosis in vitro.ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas.Suppression of Hedgehog signalling promotes pro-tumourigenic integrin expression and function.Oral submucous fibrosis: An update on pathophysiology of malignant transformation.Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis.EGCG blocks TGFβ1-induced CCN2 by suppressing JNK and p38 in buccal fibroblasts.Role of TGF-β and BMP7 in the pathogenesis of oral submucous fibrosis.Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma.Aberrant SSEA-4 upregulation mediates myofibroblast activity to promote pre-cancerous oral submucous fibrosisThe role of tumour stroma in colorectal cancer invasion and metastasis.Expression of αvβ6 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications.Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4.Adverse Health Effects of Betel Quid and the Risk of Oral and Pharyngeal Cancers.Emerging role of Twist1 in fibrotic diseases.Activation of transforming growth factor-β1 by thrombin via integrins αvβ1, αvβ3, and αvβ5 in buccal fibroblasts: Suppression by epigallocatechin-3-gallate.Effect of curcumin on the expression of p53, transforming growth factor-β, and inducible nitric oxide synthase in oral submucous fibrosis: A pilot study.Arecoline-stimulated placenta growth factor production in gingival epithelial cells: modulation by curcumin.Arecoline stimulated early growth response-1 production in human buccal fibroblasts: suppression by epigallocatechin-3-gallate.An Evaluation of Clinical and Histopathological Aspects of Patients with Oral Submucous Fibrosis in the Background of Oral Squamous Cell Carcinoma
P2860
Q21134090-64391689-6B36-424A-8656-E510E454FDE6Q26775091-7F0DCEAA-F904-4A9A-BE47-51B9FE2488F6Q33838727-A2290925-D60D-4EF0-A3FF-019EF140D188Q34532301-3EF07BD9-D3E6-4101-ACF7-D5912F896A44Q34576091-F72D0E85-3D52-4C9F-83A8-62A8C59819FDQ35170178-1592A0F7-0414-4849-B61F-F04552CDB6E3Q35524640-EB134B8B-40B3-49C9-8240-792D7715F4B8Q36174374-2F82B94F-133B-4BD6-AD66-0B84908ED8BDQ36287412-02140BB1-955E-427D-89AF-FEF85B0B9AB4Q37724033-B1FB98B7-E647-4254-9DE0-3A872F42064DQ38188018-28837CC2-D8BE-4803-ADCC-F13A4DA03AB0Q38831902-29CD53D9-91A4-4885-AC68-C56BEF2E77C2Q38885844-AC19E91C-22F2-435C-A995-9C30C5885B05Q38943076-6734E0BF-D10F-4C44-B3F5-6D3E28DE2DC8Q39020546-BC547757-3682-462D-88FB-CA05337579F1Q39229606-EFB96951-36D1-4CFE-9F55-8F49B3669C80Q39243513-B701693A-08D6-40B5-8053-66C17846AE4FQ39380356-32FEFD32-15CB-4992-9261-E8FB542C5C21Q39540430-FCEB2070-8136-48E6-936D-4BF5A5344F99Q39909899-6638163B-036A-4F9E-BFC5-88FB7F954DEFQ42368725-8A0BBA3D-E141-4241-B755-43970DE2AAF2Q42576948-D15AF5FE-274A-4D35-BBB6-6D14C21E3127Q44848389-9A9C7700-9485-49E1-A901-7DDA5C47E887Q46304951-D0F365DD-D5E4-42FB-A15E-E3CE37DD62E6Q47708275-A1E57BD4-B5A4-4F93-BC87-8635063C47F2Q48285933-A63BC038-6F5C-412A-B3FC-D8705638C862Q51024108-2327D8DC-4E82-4E30-820B-7869268486BCQ51252645-BA538880-8325-412C-AFB7-E7A420F440E7Q54283108-474F764C-46B4-415A-8912-8EAE5D865D1DQ54383842-B93458A9-1737-4EA9-B892-92723766544CQ58577725-81F932D5-B8E0-4DF9-9E96-608C473CFEA8
P2860
Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Betel-derived alkaloid up-regu ...... motes oral submucous fibrosis.
@en
Betel-derived alkaloid up-regu ...... motes oral submucous fibrosis.
@nl
type
label
Betel-derived alkaloid up-regu ...... motes oral submucous fibrosis.
@en
Betel-derived alkaloid up-regu ...... motes oral submucous fibrosis.
@nl
prefLabel
Betel-derived alkaloid up-regu ...... motes oral submucous fibrosis.
@en
Betel-derived alkaloid up-regu ...... motes oral submucous fibrosis.
@nl
P2093
P2860
P50
P356
P1476
Betel-derived alkaloid up-regu ...... omotes oral submucous fibrosis
@en
P2093
Daniel Marsh
Farida Fortune
Gareth J Thomas
Ian R Hart
Karen Sapienza
Karwan A Moutasim
Shelia M Violette
Veronika Jenei
Waninayaka M Tilakaratne
P2860
P304
P356
10.1002/PATH.2786
P577
2010-10-25T00:00:00Z